Epidemiological and genetic analysis of severe acute respiratory syndrome.

PubWeight™: 1.43‹?› | Rank: Top 5%

🔗 View Article (PMID 15522679)

Published in Lancet Infect Dis on November 01, 2004

Authors

Christl A Donnelly1, Matthew C Fisher, Christophe Fraser, Azra C Ghani, Steven Riley, Neil M Ferguson, Roy M Anderson

Author Affiliations

1: Department of Infectious Disease Epidemiology, Faculty of Medicine, Imperial College, London, UK. c.donnelly@imperial.ac.uk <c.donnelly@imperial.ac.uk>

Articles citing this

Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis (2009) 4.33

Optimizing infectious disease interventions during an emerging epidemic. Proc Natl Acad Sci U S A (2009) 1.92

Maximum likelihood estimation of the negative binomial dispersion parameter for highly overdispersed data, with applications to infectious diseases. PLoS One (2007) 1.84

Modeling control strategies of respiratory pathogens. Emerg Infect Dis (2005) 1.79

Rethinking biosafety in research on potential pandemic pathogens. MBio (2012) 1.39

Using routine surveillance data to estimate the epidemic potential of emerging zoonoses: application to the emergence of US swine origin influenza A H3N2v virus. PLoS Med (2013) 1.37

Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants. PLoS Med (2006) 1.34

Frequent travelers and rate of spread of epidemics. Emerg Infect Dis (2007) 1.29

Early efforts in modeling the incubation period of infectious diseases with an acute course of illness. Emerg Themes Epidemiol (2007) 1.12

Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection. J Virol (2009) 1.05

Media impact switching surface during an infectious disease outbreak. Sci Rep (2015) 0.92

OX40:OX40L axis: emerging targets for improving poxvirus-based CD8(+) T-cell vaccines against respiratory viruses. Immunol Rev (2011) 0.82

Effectiveness of traveller screening for emerging pathogens is shaped by epidemiology and natural history of infection. Elife (2015) 0.79

Articles by these authors

Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature (2005) 30.92

Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections. N Engl J Med (2014) 28.65

Pandemic potential of a strain of influenza A (H1N1): early findings. Science (2009) 26.24

Strategies for mitigating an influenza pandemic. Nature (2006) 25.20

Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science (2003) 12.26

Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet (2003) 10.74

Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol (2008) 10.02

Rapid pneumococcal evolution in response to clinical interventions. Science (2011) 9.09

Factors that make an infectious disease outbreak controllable. Proc Natl Acad Sci U S A (2004) 8.38

Modeling targeted layered containment of an influenza pandemic in the United States. Proc Natl Acad Sci U S A (2008) 8.27

Estimating the impact of school closure on influenza transmission from Sentinel data. Nature (2008) 7.98

Sexual mixing patterns and sex-differentials in teenage exposure to HIV infection in rural Zimbabwe. Lancet (2002) 7.64

HIV decline associated with behavior change in eastern Zimbabwe. Science (2006) 6.98

Closure of schools during an influenza pandemic. Lancet Infect Dis (2009) 6.68

Assessing the severity of the novel influenza A/H1N1 pandemic. BMJ (2009) 6.66

Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N Engl J Med (2009) 6.65

HIV-1 transmission, by stage of infection. J Infect Dis (2008) 6.57

The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study. Lancet (2011) 5.87

The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis. PLoS Med (2009) 5.86

Submicroscopic infection in Plasmodium falciparum-endemic populations: a systematic review and meta-analysis. J Infect Dis (2009) 5.73

The effect of public health measures on the 1918 influenza pandemic in U.S. cities. Proc Natl Acad Sci U S A (2007) 5.73

Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategies. PLoS Med (2010) 5.71

Factors determining the occurrence of submicroscopic malaria infections and their relevance for control. Nat Commun (2012) 5.34

Can we reverse the HIV/AIDS pandemic with an expanded response? Lancet (2002) 5.21

Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg Infect Dis (2009) 4.71

Planning for smallpox outbreaks. Nature (2003) 4.16

HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med (2012) 4.08

Estimation of the reproductive number and the serial interval in early phase of the 2009 influenza A/H1N1 pandemic in the USA. Influenza Other Respir Viruses (2009) 4.02

Will travel restrictions control the international spread of pandemic influenza? Nat Med (2006) 3.89

Reducing the impact of the next influenza pandemic using household-based public health interventions. PLoS Med (2006) 3.86

Public health. Public health risk from the avian H5N1 influenza epidemic. Science (2004) 3.71

The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin Infect Dis (2010) 3.51

Fuzzy species among recombinogenic bacteria. BMC Biol (2005) 3.47

School closure and mitigation of pandemic (H1N1) 2009, Hong Kong. Emerg Infect Dis (2010) 3.42

Host immunity and synchronized epidemics of syphilis across the United States. Nature (2005) 3.34

Managing and reducing uncertainty in an emerging influenza pandemic. N Engl J Med (2009) 3.31

New strategies for the elimination of polio from India. Science (2006) 3.27

CD4 cell counts of 800 cells/mm3 or greater after 7 years of highly active antiretroviral therapy are feasible in most patients starting with 350 cells/mm3 or greater. J Acquir Immune Defic Syndr (2007) 3.18

Dried blood spots as a source of anti-malarial antibodies for epidemiological studies. Malar J (2008) 3.02

West African Ebola epidemic after one year--slowing but not yet under control. N Engl J Med (2014) 2.96

Methods for monitoring influenza surveillance data. Int J Epidemiol (2006) 2.88

Real-time estimates in early detection of SARS. Emerg Infect Dis (2006) 2.87

Potential impact of antiretroviral chemoprophylaxis on HIV-1 transmission in resource-limited settings. PLoS One (2007) 2.84

Role of social networks in shaping disease transmission during a community outbreak of 2009 H1N1 pandemic influenza. Proc Natl Acad Sci U S A (2011) 2.79

Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity. PLoS Med (2008) 2.78

Multiple emergences of genetically diverse amphibian-infecting chytrids include a globalized hypervirulent recombinant lineage. Proc Natl Acad Sci U S A (2011) 2.78

Mortality and progression to AIDS after starting highly active antiretroviral therapy. AIDS (2003) 2.78

Scale-free networks and sexually transmitted diseases: a description of observed patterns of sexual contacts in Britain and Zimbabwe. Sex Transm Dis (2004) 2.75

Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials. Malar J (2008) 2.68

Seasonal infectious disease epidemiology. Proc Biol Sci (2006) 2.62

Estimation of the serial interval of influenza. Epidemiology (2009) 2.60

Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs. Malar J (2010) 2.58

Impact and process evaluation of integrated community and clinic-based HIV-1 control: a cluster-randomised trial in eastern Zimbabwe. PLoS Med (2007) 2.56

Hyper-recombination, diversity, and antibiotic resistance in pneumococcus. Science (2009) 2.54

The emerging amphibian pathogen Batrachochytrium dendrobatidis globally infects introduced populations of the North American bullfrog, Rana catesbeiana. Biol Lett (2006) 2.53

Costs and cost-effectiveness of malaria control interventions--a systematic review. Malar J (2011) 2.53

Climate change and outbreaks of amphibian chytridiomycosis in a montane area of Central Spain; is there a link? Proc Biol Sci (2007) 2.53

Modelling the impact of antiretroviral use in resource-poor settings. PLoS Med (2006) 2.52

Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol (2004) 2.47

Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic. Philos Trans R Soc Lond B Biol Sci (2004) 2.45

Long-term evolution and transmission dynamics of swine influenza A virus. Nature (2011) 2.39

Study of bias in antenatal clinic HIV-1 surveillance data in a high contraceptive prevalence population in sub-Saharan Africa. AIDS (2002) 2.36

The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients. Ann Intern Med (2004) 2.36